Our Mission 

• To provide unique enabling technology to accelerate the rate of drug discovery and development through the synergistic relationships between chemistry, cell biology, pharmacology, and computer science.
 
• To help decrease the need to use animals in pharmaceutical and biopharmaceutical research, by developing superior in-vitro systems and models to replace their inefficient and expensive in-vivo animal equivalents.
 

Company History

Prior to G2 Research these models and the related data were developed at NaviCyte Inc., which was acquired by Trega Biosciences. Trega was in turn acquired by LION bioscience.  

When LION bioscience ceased operations as an informatics company, G2 Research acquired the exclusive rights to the patents, data, models and tools used in building and validating the ADME predictive models first developed by NaviCyte. 

We are now offering these assets to those who wish to develop ADME models or to enhance existing models by using our models, our databases, or our tools for model development.

If you have questions about any of the assets which are not yet offered on this site, please contact us.

Company Contact:

G2 Research

PO Box 1242

Tahoe City, California 96145

Email: g2research@mac.com
Phone: 754-444-ADME (754-444-2363)